Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep;37(9).
doi: 10.1002/gps.5800.

Medication-related problems in geriatric psychiatry-a retrospective cohort study

Johannes Heck  1   2 , Christian Ihlefeld  2   3 , Olaf Krause  4   5 , Dirk O Stichtenoth  1   6 , Martin Schulze Westhoff  2 , Nina Noltemeyer  2 , Kirsten Jahn  2 , Lea Prost  7 , Swetlana Gerbel  7 , Martin Klietz  8 , Stefan Bleich  2 , Helge Frieling  2 , Adrian Groh  2
Affiliations

Medication-related problems in geriatric psychiatry-a retrospective cohort study

Johannes Heck et al. Int J Geriatr Psychiatry. 2022 Sep.

Abstract

Objectives: Information on medication-related problems (MRPs) in elderly psychiatric patients is scarce. In the present study, we analyzed the frequency and characteristics of MRPs in patients ≥60 years treated on the gerontopsychiatric ward of Hannover Medical School in 2019.

Methods: Taking advantage of an interdisciplinary approach, two independent investigators screened hospital discharge letters of 230 psychiatric inpatients for clinically relevant MRPs, followed by validation through an interdisciplinary expert panel. Drug interactions as a subset of MRPs were analyzed with the aid of two different drug interaction programs.

Results: 230 patients (63.0% female, mean age 73.7 ± 8.4 years, median length of stay 18 days) were prescribed a median of 6 drugs. In total, 2180 MRPs were detected in the study population and 94.3% of the patients exhibited at least one MRP. Patients displayed a median of 7 MRPs (interquartile range 3-15). Pharmacodynamic interactions accounted for almost half of all MRPs (48.1%; 1048/2180). The number of drugs prescribed and the number of MRPs per patient showed a strong linear relationship (adjusted R2 = 0.747).

Conclusion: An exceedingly high proportion of elderly psychiatric inpatients displayed clinically relevant MRPs in the present study, which may be explained by the multimorbidity prevalent in the study population and the associated polypharmacy. The number of drug interactions was largely in accordance with previous studies. As a novel finding, we detected that a considerable proportion of elderly psychiatric inpatients were affected by potential prescribing omissions, potentially inappropriate duplicate prescriptions, and insufficient documentation.

Keywords: adverse drug reactions; drug-drug interactions; geriatric psychiatry; medication-related problems; pharmacotherapy safety.

PubMed Disclaimer

References

REFERENCES

    1. European Medicines Agency. ICH Guideline E7 Studies in Support of Special Populations: Geriatrics; 1994.
    1. Marengoni A, Onder G. Guidelines, polypharmacy, and drug-drug interactions in patients with multimorbidity. BMJ. 2015;350(mar11 4):h1059. https://doi.org/10.1136/bmj.h1059
    1. Davies EA, O'Mahony MS. Adverse drug reactions in special populations-the elderly. Br J Clin Pharmacol. 2015;80(4):796-807. https://doi.org/10.1111/bcp.12596
    1. Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004;57(1):6-14. https://doi.org/10.1046/j.1365-2125.2003.02007.x
    1. van Mil JW, Westerlund LO, Hersberger KE, Schaefer MA. Drug-related problem classification systems. Ann Pharmacother. 2004;38(5):859-867. https://doi.org/10.1345/aph.1d182

Publication types